Tempus wants to be the operating system for cancer care. Co-founded by Eric Lefkofsky, the company plans to revolutionize not only how everyday patient data is used and stored, but also what types are being utilized. Tempus wants to do through this by making a person’s genetic information a regularly accessed part of their health care.
At a once extremely prohibitive cost over upwards of one hundred million dollars, the cost is predicted to drop to only a few hundred dollars in the foreseeable future. Currently standing at around five thousand, with the help of companies like Tempus, what once seemed straight out of science fiction could be reality. Care could be determined on a molecular level.
A patient’s genetic information is a potential key to find the best treatments available for a particular person’s case and type of cancer. This could also be utilized on a global scale to compare the information from patients and discover links to possible cures. Preventative medicine will also be a huge part of Tempus’ system. By knowing what someone is predisposed to, care can begin before the disease starts.
Tempus’ software is also designed to optically recognize hand-written notes and convert them into utilizable and searchable data. Eric Lefkofsky observed this was a problem when he noticed how much information was lost during his wife’s breast cancer treatments. Very important data was being lost as it was not being saved.
Eric Lefkofsky, a graduate of the University of Michigan with a Juris Doctor, has both success in business and his philanthropic endeavors. Members of the Giving Pledge and having recently donated millions to cancer initiatives, he and his wife are to donate half or more of their assets. Co-founded the Lefkofsky Foundation, the pair fund and assist initiatives that enhance the lives of those in and around the Chicago area. Lefkofsky acts as a trustee at the Lurie Children’s Hospital of Chicago as well as the Museum of Science and Industry.
For More info: www.lightbank.com/team/eric-lefkofsky